IGF2BP3 and Miyoshi myopathy: To test if IGF2BP1 and IGF2BP3 are bona fide targets of miR-9-5p, we transfected MM cells with miR-9-5p precursor, or scramble control and measured IGF2BP1 and IGF2BP3 protein expression by western blot.